SOUTH SAN FRANCISCO, Calif., March 27, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has entered into a settlement agreement with Annora Pharma Private ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
SOUTH SAN FRANCISCO – Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a pharmaceutical company with impressive revenue growth of 54.71% over the last twelve months, has reached a settlement with ...
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported fourth-quarter earnings of $14.3 million. On a per-share basis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback